531210 — Colinz Laboratories Balance Sheet

0.000.00%

Last trade - 00:00

HealthcareHighly SpeculativeMicro CapNeutral

Annual balance sheet for Colinz Laboratories, fiscal year end - March 31st, INR millions except per share, conversion factor applied.

	2022 March 31st	2023 March 31st	2024 March 31st	2025 March 31st	2026 March 31st
Period Length:	—	—	—	—	—
Source:	ARS	ARS	ARS	ARS	PRESS
Standards:	IAS	IAS	IAS	IAS	—
Status:	Final	Final	Final	Final	Final
Cash
Cash and Equivalents
Cash and Short Term Investments	52.1	57.3	70	55.5	85.3
Net Total Accounts Receivable
Net Total Receivables	12.1	11.3	8.59	6.61	8.35
Total Inventory
Total Other Current Assets
Total Current Assets	73.8	78.4	87.4	90.2	101
Net Property, Plant And Equipment	18.6	17.1	15.8	17	15.4
Long Term Investments
Long Term Notes Receivable
Total Assets	99.3	102	114	118	128
Accounts Payable
Notes Payable / Short Term Debt
Total Other Current Liabilities
Total Current Liabilities	19.8	18.9	21.8	21.6	25.7
Total Long Term Debt
Total Debt
Deferred Income Tax
Total Other Liabilities
Total Liabilities	22.4	20.9	24.1	23.4	27.4
Common Stock
Retained Earnings (Accumulated Deficit)
Total Equity	76.9	81.4	89.5	94.7	100
Total Liabilities & Shareholders' Equity	99.3	102	114	118	128
Total Common Shares Outstanding